Sinil Pharm’s Q2 operating profit down 5.27%

[DISCLOSURE] Sinil Pharm (012790) announced on Aug. 8 that its Q2 operating profit declined 5.27 percent to 2.8 billion won (US$2.5 million) on-year.

Sales rose 10.75 percent to 12.2 billion won and net profit increased 10.01 percent to 2.6 billion won.